Medical Director/Global Medical Indication Lead - Nephrology(FSP)
Thermo Fisher Scientific- Full Time
- Junior (1 to 2 years)
Candidates must hold an M.D. or Ph.D. degree, with a minimum of five years of post-fellowship practice experience in GI Oncology, involving the treatment of patients. They should possess knowledge of practice guidelines across various GI cancer types and at least three years of clinical trial experience in academia, the biotech industry, or a comparable setting. Furthermore, a minimum of two years of experience in industry, specifically in Medical Affairs or Clinical Development, with a proven track record of successfully commercializing transplant products (therapeutics or diagnostics) is preferred.
The Associate Medical Director will collaborate with the Medical Director, Oncology, on the clinical development of molecular diagnostic tools for heart transplant and heart failure, lead the design and implementation of new treatment protocols, recruit industry-leading Principal Investigators and clinical sites for studies, advise on product development, identify clinical needs and opportunities, provide medical interpretation of test results, support physician customers, advise on pre-and post-test counseling for patients, drive medical education efforts, support the publication strategy, provide medical input into regulatory submissions, represent Natera’s medical voice in public relations, maintain HIPAA/PHI privacy compliance, complete relevant training, and maintain current training requirements. They will also be willing to travel over 40% of the time, focusing on transplant-related activities.
Genetic testing and diagnostics solutions provider
Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.